[{"address1": "9704 Medical Center Drive", "city": "Rockville", "state": "MD", "zip": "20850", "country": "United States", "phone": "301 251 5172", "fax": "301 251 5321", "website": "https://www.macrogenics.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "MacroGenics, Inc., a clinical-stage biopharmaceutical company, discovers, develops, manufactures, and commercializes antibody-based therapeutics to treat cancer in the United States. The company's product pipeline includes lorigerlimab, a bispecific DART molecule that targets checkpoint inhibitors PD-1 and CTLA-4 for the treatment of mCRPC and docetaxel that is in phase 2 clinical trials, as well as for the treatment of platinum-resistant ovarian cancer and clear cell gynecologic cancer which has completed phase 1 clinical trial; MGC026, an ADC that targets B7-H3 and delivers a novel topoisomerase I inhibitor (TOP1i)-based linker-payload; MGC028, an antibody-drug conjugates (ADC) that targets ADAM9 and delivers a novel TOP1i-based linker-payload for the treatment of solid tumors, which is in phase 1 clinical trials; MGC030, a ADC molecule for the treatment of solid tumors, which is in preclinical trials. It is also developing next generation T-cell engager programs. The company has collaborations with TerSera Therapeutics LLC; Incyte Corporation; and Gilead Sciences, Inc. MacroGenics, Inc. was incorporated in 2000 and is headquartered in Rockville, Maryland.", "fullTimeEmployees": 341, "companyOfficers": [{"maxAge": 1, "name": "Mr. James  Karrels", "age": 57, "title": "Senior VP, CFO & Corporate Secretary", "yearBorn": 1967, "fiscalYear": 2024, "totalPay": 663431, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Stephen L. Eck M.D., Ph.D.", "age": 69, "title": "Senior VP of Clinical Development & Chief Medical Officer", "yearBorn": 1955, "fiscalYear": 2024, "totalPay": 735308, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Eric Blasius Risser", "age": 51, "title": "CEO, President & Director", "yearBorn": 1973, "fiscalYear": 2024, "totalPay": 651362, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Thomas M. Spitznagel Ph.D.", "age": 57, "title": "Senior Vice President of Technical Operations", "yearBorn": 1967, "fiscalYear": 2024, "totalPay": 550974, "exercisedValue": 204497, "unexercisedValue": 490417}, {"maxAge": 1, "name": "Dr. Ezio  Bonvini M.D.", "age": 70, "title": "Senior VP of Research & Chief Scientific Officer", "yearBorn": 1954, "fiscalYear": 2024, "totalPay": 612208, "exercisedValue": 264031, "unexercisedValue": 199063}, {"maxAge": 1, "name": "Mr. Jeffrey Stuart Peters J.D.", "age": 53, "title": "Senior VP, General Counsel & Corporate Compliance Officer", "yearBorn": 1971, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 6, "boardRisk": 3, "compensationRisk": 7, "shareHolderRightsRisk": 7, "overallRisk": 6, "governanceEpochDate": 1754006400, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.44, "open": 1.53, "dayLow": 1.51, "dayHigh": 1.7, "regularMarketPreviousClose": 1.44, "regularMarketOpen": 1.53, "regularMarketDayLow": 1.51, "regularMarketDayHigh": 1.7, "payoutRatio": 0.0, "beta": 1.656, "forwardPE": -0.70124483, "volume": 1496537, "regularMarketVolume": 1496537, "averageVolume": 1276298, "averageVolume10days": 576600, "averageDailyVolume10Day": 576600, "bid": 1.66, "ask": 1.71, "bidSize": 2, "askSize": 2, "marketCap": 106817640, "fiftyTwoWeekLow": 0.99, "fiftyTwoWeekHigh": 5.1, "priceToSalesTrailing12Months": 0.64544326, "fiftyDayAverage": 1.5068, "twoHundredDayAverage": 2.2321, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 37838640, "profitMargins": -0.21993999, "floatShares": 52660464, "sharesOutstanding": 63205700, "sharesShort": 4044082, "sharesShortPriorMonth": 4522294, "sharesShortPreviousMonthDate": 1751241600, "dateShortInterest": 1753920000, "sharesPercentSharesOut": 0.0641, "heldPercentInsiders": 0.032509997, "heldPercentInstitutions": 0.80424005, "shortRatio": 5.19, "shortPercentOfFloat": 0.0789, "impliedSharesOutstanding": 63205700, "bookValue": 0.738, "priceToBook": 2.289973, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -36399000, "trailingEps": -0.57, "forwardEps": -2.41, "enterpriseToRevenue": 0.229, "enterpriseToEbitda": -0.537, "52WeekChange": -0.5252809, "SandP52WeekChange": 0.1513431, "quoteType": "EQUITY", "currentPrice": 1.69, "targetHighPrice": 5.0, "targetLowPrice": 2.0, "targetMeanPrice": 3.4, "targetMedianPrice": 3.0, "recommendationMean": 2.57143, "recommendationKey": "hold", "numberOfAnalystOpinions": 5, "totalCash": 176486000, "totalCashPerShare": 2.792, "ebitda": -70462000, "totalDebt": 107507000, "quickRatio": 4.847, "currentRatio": 5.255, "totalRevenue": 165495008, "debtToEquity": 230.613, "revenuePerShare": 2.631, "returnOnAssets": -0.21841998, "returnOnEquity": -0.69705003, "grossProfits": -16094000, "freeCashflow": -50392248, "operatingCashflow": -72120000, "revenueGrowth": 1.06, "grossMargins": -0.09725001, "ebitdaMargins": -0.42576998, "operatingMargins": -1.65271, "financialCurrency": "USD", "symbol": "MGNX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "postMarketTime": 1755907132, "regularMarketTime": 1755892801, "exchange": "NMS", "messageBoardId": "finmb_600911", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1381411800000, "postMarketChangePercent": 0.0, "postMarketPrice": 1.69, "postMarketChange": 0.0, "regularMarketChange": 0.25, "regularMarketDayRange": "1.51 - 1.7", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 1276298, "fiftyTwoWeekLowChange": 0.70000005, "fiftyTwoWeekLowChangePercent": 0.70707077, "fiftyTwoWeekRange": "0.99 - 5.1", "fiftyTwoWeekHighChange": -3.4099998, "fiftyTwoWeekHighChangePercent": -0.66862744, "fiftyTwoWeekChangePercent": -52.528088, "earningsTimestampStart": 1762286400, "earningsTimestampEnd": 1762286400, "earningsCallTimestampStart": 1742502600, "earningsCallTimestampEnd": 1742502600, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -0.57, "epsForward": -2.41, "epsCurrentYear": -1.71, "priceEpsCurrentYear": -0.9883041, "fiftyDayAverageChange": 0.1832, "fiftyDayAverageChangePercent": 0.12158216, "twoHundredDayAverageChange": -0.54209995, "twoHundredDayAverageChangePercent": -0.24286544, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "2.6 - Hold", "cryptoTradeable": false, "regularMarketPrice": 1.69, "shortName": "MacroGenics, Inc.", "longName": "MacroGenics, Inc.", "corporateActions": [], "regularMarketChangePercent": 17.3611, "marketState": "CLOSED", "displayName": "MacroGenics", "trailingPegRatio": null, "__fetch_time": "2025-08-23"}]